Maroun, J. (2011). The significance of progression-free survival as an endpoint in evaluating the therapeutic value of antineoplastic agents. Multimed Inc.
Citação norma ChicagoMaroun, J.A. The Significance of Progression-free Survival As an Endpoint in Evaluating the Therapeutic Value of Antineoplastic Agents. Multimed Inc, 2011.
ציטוט MLAMaroun, J.A. The Significance of Progression-free Survival As an Endpoint in Evaluating the Therapeutic Value of Antineoplastic Agents. Multimed Inc, 2011.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.